Body Composition of Infants: Follow-up to Placenta and Cord Blood Analyses

This study has been withdrawn prior to enrollment.
(determined not enough participants would be able to be enrolled and not enough data collected for good analyses)
Information provided by (Responsible Party):
University of Arkansas Identifier:
First received: October 31, 2011
Last updated: April 30, 2012
Last verified: April 2012
Investigators will characterize the body composition and metabolism of infants born from lean, overweight or obese mothers from whom they had previously obtained a placenta and/or cord blood as part of the earlier placenta and cord blood study (#111576)

Infant Body Composition and Metabolism

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Body Composition of Infants: Follow-up to Placenta and Cord Blood Analyses

Further study details as provided by University of Arkansas:

Biospecimen Retention:   Samples With DNA
Blood, urine, and a cheek swab may be collected from study participants

Enrollment: 0
Study Start Date: October 2011
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   3 Months to 21 Months
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
infants age 12 months (+/- 9 months)

Inclusion Criteria:

  • mother's prior participation in study #111576 with successful collection of placenta
  • infant age 12 months (+/- 9 months)

Exclusion Criteria:

  • mother did not participate in study #111576
  • mother did participate in study #111576, but collection of placenta was not successful
  • infant not age 12 months (+/- 9 months)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01464684

Sponsors and Collaborators
University of Arkansas
Principal Investigator: Aline Andres, PhD University of Arkansas
  More Information

No publications provided

Responsible Party: University of Arkansas Identifier: NCT01464684     History of Changes
Other Study ID Numbers: 132624
Study First Received: October 31, 2011
Last Updated: April 30, 2012
Health Authority: United States: Food and Drug Administration processed this record on November 27, 2015